CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Life Sciences Review

Cancer Immunotherapy

The Revolutionary Power of Cell and Gene Therapies

The Revolutionary Power of Cell and Gene Therapies

Stefano Baila

Managing Director support Biologics (Cell and Gene)

Eurofins

The Cancer Immunotherapy Treatment Paradigm

Charles G. Drake

M.D., Ph.D., Vice President, Immuno-Oncology

the Janssen Pharmaceutical Companies of Johnson & Johnson

Featured Issue
#

Expanding the Promise of Immunotherapy Beyond the Oncology Realm

James Riddle, MCSE, CIP, CPIA, CRQM, Senior Vice President - Global Review Operations Advarra
#

Patient-Centric Approach to Accelerating Clinical Trials

Anita Nelsen, Senior Vice President, Clinical Trial Operations, Allucent
#

Immunotherapy in Lung Cancer: building towards a patient-tailored future

James Holland, PhD, Associate Scientific Director, and Kindiya Geghman, PhD, Vice President, Medical & Scientific Services, Ashfield MedComms An Inizio Company
#

Accelerating Early-Stage Drug Development

Safwan Kezbor, M.D., Global Medical Lead (Senior Medical Director) Shionogi Inc
Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Setting A Culture for Digital Transformation in the Biopharmaceutical Industry

Ross Kenyon, P.E., Associate Director, Modeling, Simulation and Analysis

Regeneron Pharmaceuticals, Inc.

Progress in Cancer Research by Manufacturing Tough Proteins

Progress in Cancer Research by Manufacturing Tough Proteins

Dr. Rob Burgess, Chief Business Officer

Sino Biological

#

Bolstering Next Generation Cancer Treatment

Pierre-Emmanuel Gerard, CEO and Founder

News

Clinical Trial Management Moves Toward A More Connected Model

Biomarker Claims Face Evidence Test

Choosing an ADC and AOC CDMO Partner for Complex Bioconjugates

Biomarker Results Leave Decisions Open

Loading...

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://cancer-immunotherapy.lifesciencesreview.com